Article
CNBC
(2020)
The ACTIV-3 trial is one of several ongoing trials that are part of an NIH program to accelerate the development of vaccine treatments.
FoundryBase
updated 9 months ago
0 likes
MORE RESOURCES FROM SOURCE
More from FoundryBase CNBC